| Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis (NCT04849065) | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | 2021-05-01 |
| Psilocybin Versus Ketamine in Treatment-Resistant Depression (NCT05383313) | National Institute of Mental Health, Czech Republic | 2021-05-01 |
| The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis (NCT05931744) | Kafrelsheikh University | 2021-05-01 |
| Efficacy of Adipose Derived Stromal Vascular Fraction in the Treatment of Keloids (NCT04391621) | Makerere University | 2021-05-01 |
| Albuvirtide in Combination With 3BNC117 in Virologically Suppressed Subjects With HIV-1 Infection (NCT04819347) | Frontier Biotechnologies Inc. | 2021-05-01 |
| Auricular Muscle Zone Stimulation for Parkinson Disease (NCT04652583) | Stoparkinson Healthcare Systems LLC | 2021-05-01 |
| Opioid Modulation and Neural Reward Activation in Healthy Adults (NCT04854551) | University of Colorado, Denver | 2021-05-01 |
| Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCC (NCT04843943) | Fudan University | 2021-05-01 |
| Effects of Intensive Training on Reocvery of Fingers Dexterity Following Stroke (NCT04229329) | Loewenstein Hospital | 2021-05-01 |
| Clinical Trial Assessing Non-Inferiority of Freeze Dried Plasma to Fresh Frozen Plasma in Reversing Warfarin (NCT04794348) | Teleflex | 2021-05-01 |
| A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma (NCT04860674) | Zhejiang Cancer Hospital | 2021-05-01 |
| mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRC (NCT04895137) | Sixth Affiliated Hospital, Sun Yat-sen University | 2021-05-01 |
| Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy (NCT04661514) | University of California, San Diego | 2021-05-01 |
| Surufatinib in Recurrent/Metastatic Head and Neck Adenocarcinomas (NCT04910854) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2021-05-01 |
| cTACE Plus Sintilimab for Unresectable Intermediate-stage HCC With Beyond Up-to-seven Criteria (NCT04842565) | Fudan University | 2021-05-01 |
| Injection Free IVF (NCT04850261) | Insel Gruppe AG, University Hospital Bern | 2021-05-01 |
| A Prospective, Single Center Clinical Study of Toripalimab Combined With FLOT Regimen for Perioperative Treatment of PD-L1 Positive Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GEJ) (NCT05466019) | The First Hospital of Jilin University | 2021-05-01 |
| Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC. (NCT04882462) | The First Affiliated Hospital of Soochow University | 2021-05-01 |
| Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS (NCT05175508) | The First Affiliated Hospital of Soochow University | 2021-05-01 |
| 18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer (NCT04727736) | Ashok Muthukrishnan | 2021-05-01 |
| Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 ) (NCT04863079) | Tianjin Medical University Cancer Institute and Hospital | 2021-05-01 |
| A Phase I/II Study of Diffuse Large B-cell Lymphoma (NCT04856137) | National Health Research Institutes, Taiwan | 2021-05-01 |
| Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year (NCT04455958) | OHSU Knight Cancer Institute | 2021-05-01 |
| the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer (NCT04978753) | Li-kun Chen | 2021-05-01 |
| Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial (NCT05223582) | Fudan University | 2021-05-01 |
| Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung Cancer (NCT04542369) | Shanghai Pulmonary Hospital, Shanghai, China | 2021-05-01 |
| Essential Amino Acid Supplementation in Older Adult COVID-19 Patients (NCT04816071) | University of Arkansas | 2021-05-01 |
| Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (NCT04908566) | Tianjin Medical University Cancer Institute and Hospital | 2021-05-01 |
| Adjuvant Chemotherapy and Anti-PD-1 Antibody in Patients With Stage IIIC2-IVB Cervical Cancer (NCT04918628) | Taizhou Hospital | 2021-05-01 |
| Safety and Efficacy of Maraviroc in Post-stroke Cognitive Impairment (NCT04966429) | Tel-Aviv Sourasky Medical Center | 2021-05-01 |
| Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer (NCT04518280) | Fudan University | 2021-05-01 |
| Laser Acupuncture for Meniere Disease (NCT06544434) | Beijing Tongren Hospital | 2021-05-01 |
| CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome (NCT03929211) | Wake Forest University Health Sciences | 2021-05-01 |
| Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients (NCT03084952) | Infan Industria Quimica Farmaceutica Nacional | 2021-05-01 |
| Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients (NCT05395143) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2021-05-01 |
| A Phase 1/2 Study of SC-43 in Combination With Cisplatin (NCT04733521) | RaND Biosciences | 2021-05-01 |
| Effect of N-Acetylcysteine on Neutrophil Lymphocyte Ratio And Length of Stay In COVID-19 Patients (NCT05658549) | Universitas Sebelas Maret | 2021-05-01 |
| Melatonin on Clock Genes in Parkinson's Disease (NCT04287543) | Instituto Mexicano del Seguro Social | 2021-05-01 |
| Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate (NCT04736108) | West China Hospital | 2021-05-01 |
| Nedaplatin in Treatment for Nasopharyngeal Carcinoma (NCT04834206) | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 2021-05-01 |
| Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases (NCT04834089) | Butantan Institute | 2021-05-01 |
| A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma (NCT04886765) | AlaMab Therapeutics (Shanghai) Inc. | 2021-05-01 |
| A Multi-center, Non-randomized, Open-label Phase II Clinical Study on the Treatment of Newly Diagnosed Advanced Hodgkin's Lymphoma With PD-1 Antibody (Tislelizumab) Combined With AVD Regimen (Doxorubicin, Vindesine, Dacarbazine) Under the Guidance of PET/CT (NCT04843267) | Sun Yat-sen University | 2021-05-01 |
| BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS (NCT04827719) | Groupe Francophone des Myelodysplasies | 2021-05-01 |
| Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models (NCT04646837) | Peking Union Medical College Hospital | 2021-05-01 |
| Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum (NCT04274166) | Wake Forest University Health Sciences | 2021-05-01 |
| Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial (NCT04816045) | Zealand University Hospital | 2021-05-01 |
| Melphalan Chemoreduction for Ocular Melanoma (NCT05893654) | Hospital das Clínicas de Ribeirão Preto | 2021-05-01 |
| Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery (NCT04879654) | Eye & ENT Hospital of Fudan University | 2021-05-01 |
| Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes? (NCT04882254) | Erasmus Medical Center | 2021-05-01 |
| Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4) (NCT04863248) | G1 Therapeutics, Inc. | 2021-04-30 |
| The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma (NCT04860700) | Peking Union Medical College Hospital | 2021-04-30 |
| Neoadjuvant Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms (NCT04825938) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-04-30 |
| A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant (NCT04872595) | Memorial Sloan Kettering Cancer Center | 2021-04-30 |
| Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition (NCT04847921) | University of Colorado, Denver | 2021-04-30 |
| Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines (NCT04875676) | Vaxart | 2021-04-30 |
| Prevention of COVID-19 Infection to Severe Pneumonia or ARDS (NCT04569227) | Enzychem Lifesciences Corporation | 2021-04-30 |
| Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients (NCT04863885) | H. Lee Moffitt Cancer Center and Research Institute | 2021-04-30 |
| Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast Cancer (NCT04858516) | Guangdong Provincial People's Hospital | 2021-04-30 |
| Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors (NCT04879121) | M.D. Anderson Cancer Center | 2021-04-30 |
| Restoration of Endothelial Integrity in Patients With COVID-19 (RELIC) (NCT04723589) | University of Alabama at Birmingham | 2021-04-30 |
| Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection (NCT04858425) | Entero Therapeutics | 2021-04-30 |
| TQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydrochloride Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With a High Risk of Recurrence or Metastasis (NCT04888546) | Chinese Academy of Medical Sciences | 2021-04-30 |
| Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors (NCT04615949) | Cardiol Therapeutics Inc. | 2021-04-30 |
| Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China (NCT04857164) | Yuankai Shi | 2021-04-30 |
| A Study of TAK-994 in Adults With Narcolepsy (NCT04820842) | Takeda | 2021-04-30 |
| Tislelizumab Combined With Lenvatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma (NCT04834986) | Tianjin Medical University Cancer Institute and Hospital | 2021-04-30 |
| Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents (NCT04668222) | The University of Hong Kong | 2021-04-30 |
| A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity. (NCT04752774) | Ipsen | 2021-04-29 |
| Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects (NCT03991299) | Vanderbilt University Medical Center | 2021-04-29 |
| Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL (NCT04846439) | The First Affiliated Hospital of Soochow University | 2021-04-29 |
| Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer (NCT04724928) | University Hospital, Ghent | 2021-04-29 |
| L-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive Crisis (VOC) (NCT04852172) | Asklepion Pharmaceuticals, LLC | 2021-04-29 |
| An Open-label Study to Define the Safety, Tolerability and Clinical Activity of Deutetrabenazine (AUstedo) in Adult Study Subjects With DYsTonia (NCT04173260) | University of Pennsylvania | 2021-04-29 |
| CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma (NCT04387071) | University of Southern California | 2021-04-29 |
| A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence (NCT04844840) | Sirnaomics | 2021-04-29 |
| A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST) (NCT04872543) | Memorial Sloan Kettering Cancer Center | 2021-04-29 |
| Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine (NCT05092776) | R-Pharm International, LLC | 2021-04-29 |
| Aerobic Exercise for Remyelination in Multiple Sclerosis (NCT04539002) | Oregon Health and Science University | 2021-04-29 |
| COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers (NCT04852978) | Regeneron Pharmaceuticals | 2021-04-29 |
| mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma (NCT04251715) | OHSU Knight Cancer Institute | 2021-04-28 |
| Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial) (NCT04724837) | AstraZeneca | 2021-04-28 |
| Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain. (NCT04704453) | Institut Claudius Regaud | 2021-04-28 |
| A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis (NCT05096364) | Akeso | 2021-04-28 |
| A Study of IBI302 in Patients With nAMD (NCT04820452) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-04-28 |
| Reducing Frailty for Older Cancer Survivors Using Supplements (NCT04553666) | University of Rochester | 2021-04-28 |
| Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (NCT04658472) | Bioverativ, a Sanofi company | 2021-04-28 |
| Safety and Immunogenicity of EXG-5003 (NCT04863131) | Fujita Health University | 2021-04-28 |
| A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer (NCT04838964) | Shanghai Miracogen Inc. | 2021-04-28 |
| Study to Assess Safety and PET Imaging Characteristics of a Novel Senescence-specific Radiotracer [18F]FPyGal (2-[Fluorine-18]Fluoro-3-pyridinyl-β-D-galactopyranoside) (NCT04536454) | University Hospital Tuebingen | 2021-04-28 |
| Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19 (NCT04928430) | Xenothera SAS | 2021-04-28 |
| A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy (NCT04847050) | National Cancer Institute (NCI) | 2021-04-28 |
| A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure (NCT04714320) | Ionis Pharmaceuticals, Inc. | 2021-04-28 |
| The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell Carcinoma (NCT04262427) | The Christie NHS Foundation Trust | 2021-04-28 |
| A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients (NCT04837131) | Michael M. Pham | 2021-04-28 |
| Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination (NCT04868877) | Merus B.V. | 2021-04-28 |
| Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components (NCT04377945) | Bukwang Pharmaceutical | 2021-04-28 |
| Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections (NCT04884308) | Johns Hopkins University | 2021-04-28 |
| Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours (NCT04808362) | Peptomyc S.L. | 2021-04-28 |
| Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma (NCT04948125) | Henan Cancer Hospital | 2021-04-28 |